v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows From Operating Activities:    
Net income (loss) $ (29,651) $ 89,945
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 19,458 21,357
Amortization of debt discount 892 925
Non-cash operating lease expense 3,260 5,304
Unrealized (gain) loss on investments in equity securities 4,088 (1,663)
Realized loss on available-for-sale investments 1,978 2,283
Gain on divested business   (120,047)
Stock-based compensation expense 7,143 8,601
Loss on disposal of property and equipment 164 149
Change in credit losses 230 157
Excess and obsolete inventory 602 110
Change in contingent consideration 72 (5,207)
Changes in operating assets and liabilities:    
Accounts receivable (2,964) (7,828)
Inventories 215 (2,088)
Prepaid expenses and other current assets 3,177 4,521
Deposits 55 (185)
Operating lease liabilities (2,962) (3,967)
Accounts payable and other accrued expenses 1,644 (2,723)
Accrued compensation and related expenses 1,791 (209)
Deferred revenue 523 288
Net deferred tax liability 365 778
Net cash provided by (used in) operating activities 10,080 (9,499)
Cash Flows From Investing Activities:    
Purchases of property and equipment (24,338) (10,972)
Software development costs (550) (2,649)
Proceeds from divested business   210,239
Sales/maturities of short-term investments 43,000 54,589
Patent and trademark costs (1,042) (940)
Net cash provided by investing activities 17,070 250,267
Cash Flows From Financing Activities:    
Proceeds from exercise of stock options 1,398 3,973
Repurchase of common stock   (8,004)
Repayment of 2025 Convertible Senior Notes   (14,344)
Repayment of notes payable (104) (121)
Repayment of finance lease liabilities (340) (425)
Net cash provided by (used in) financing activities 954 (18,921)
Effect of exchange rates on cash and cash equivalents 581 (11,325)
Net change in cash and cash equivalents 28,685 210,522
Cash and cash equivalents - beginning of period 250,494 45,289
Cash and cash equivalents - end of period 279,179 255,811
Reconciliation of cash and cash equivalents to the condensed consolidated balance sheets:    
Cash and cash equivalents from continuing operations - beginning of period 250,494 34,137
Cash and cash equivalents from discontinued operations (included in current assets held for sale) - beginning of period   11,152
Total cash and cash equivalents - beginning of period 250,494 45,289
Cash and cash equivalents from continuing operations - end of period 279,179 255,811
Total cash and cash equivalents - end of period 279,179 255,811
Supplemental Disclosure of Cash Flow Information:    
Cash paid for interest 776 925
Cash paid for income taxes 1,074 934
Supplemental Disclosure of Non-Cash Financing Activities:    
Operating lease right-of-use assets and operating lease liabilities 3,182 5,783
Net unrealized gain on available-for-sale debt securities 89 1,336
Reclassification of realized gain on available-for-sale debt securities to earnings 2,160 2,916
Paid-in-kind preferred stock dividend 6,000 6,000
Intangible assets included in property and equipment 3,633  
Fixed asset purchases included in accounts payable and accrued liabilities 29 229
Contingent consideration reclassed to accounts payable and accrued liabilities   881
Purchase of equipment through finance lease obligation $ 330 $ 388